Abnormally elevated bone morphogenetic protein 4 (BMP4) expression and mediated signaling 55 play critical role in the pathogenesis of chronic hypoxia-induced pulmonary hypertension (CHPH). 56
INTRODUCTION 79
Pulmonary hypertension (PH) is a disease characterized by a list of functional and structural 80 changes in the pulmonary vasculature that leads to enhanced distal PA contraction and remodeling, 81 eventually causes heart failure. During the disease process, remodeling of small vessels in the lung, 82 due to abnormal proliferation and migration of vascular smooth muscle cell and endothelium cell is 83 well studied and accepted (10) . 84
Bone morphogenetic proteins (BMPs) belong to a subgroup of the transforming growth factor 85 exposed to room air for 10 minutes every day for administering food and water, or changing cage. 130
By the end of the exposure, rats from all groups were anesthetized with pentobarbital sodium (65 131 mg/kg i.p.) and sacrificed for harvesting lung tissues. The blood in the vessel was gently completely 132 washed out with PBS to eliminate the interference of the circulation. The primary culture of distal 133 PASMC was based on an enzymatic digestion method, as previously described (39). Basically, 134 distal (>4 th generation) intralobar distal distal pulmonary arteries (PAs) were dissected from the 135 lungs. Adventitia was removed from the isolated PAs, and endothelium was denuded by opening the 136 vessel longitudinally and rubbing the luminal surface with a cotton swab. 137
138

Real-time quantitative polymerase chain reaction (RT-qPCR) 139
Total RNA was extracted using TRIzol method for de-endothelialized distal PA, as previously 140 described (21). DNA contamination in RNA preparations was removed by on-column DNase 141 digestion using RNeasy column and RNase-free DNase (Qiagen, Valencia, CA). Reverse 142 transcription was performed using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) with 143 reaction mixture containing 1 µg total RNA in a 20 µl volume. cDNA were amplified by RT-qPCR 144 using QuantiTect SYBR Green PCR Master Mix (Qiagen, Valencia, CA) in an iCyclerIQ detection 145 system (Bio-Rad, Hercules, CA). The protocol consisted of initial enzyme activation at 95°C for 3 146 min, followed by 40 cycles at 95°C for 5 s and at 60°C for 15 sec (22) . Primer sequences are 147 designed using Primer3 software and listed in Table 1 . Relative concentration of each transcript was 148 calculated using the Pfaffl method (33). Efficiency for each gene was determined from 5-point 149 serial dilutions of an unknown cDNA sample (PA or PASMC). The expression of BMP antagonists 150 were normalized to cyclophilin B as internal control. 151
152
Western Blotting 153
Lung tissue samples were sonicated or homogenized in T-PER sample buffer (Pierce, 154 Rockford, IL) containing protease inhibitor cocktail. Total protein concentration in the homogenates 155 was determined by bicinchoninic acid protein assay (Pierce, Rockford, IL) using bovine serum 156 albumin as a standard. Homogenates were denatured by adding dithiothreitol to 150 mM and 157 heating at 95 °C for 3 min. Homogenate proteins were resolved by 10% SDS-PAGE calibrated with 158
Precision Plus protein molecular weight markers (Bio-Rad, Hercules, CA). Separated proteins were 159 transferred to 0.45 µM polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Membranes 160 were blocked with 5% non-fat dry milk in Tris-buffered saline containing 0.2% Tween 20, and 161 blotted with affinity-purified polyclonal antibodies specific for TRPC1 and TRPC6 (Sigma, St. 162 Louis, Mo), MGP (Proteintech, Chicago, IL), noggin (BD Biosciences, San Jose, CA), follistatin 163 (Abcam, Cambridge, MA), and gremlin1 (Abcam, Cambridge, MA), p-p38, t-p38, p-ERK1/2, t-164 ERK1/2, p-JAK2, p-STAT3 (Cell Signaling Technology, Beverly, MA) or monoclonal antibody 165 against beta-Tubulin and beta-Actin (Sigma, St. Louis, Mo). The membranes were then washed for 166 10 minutes 3 times and incubated with horseradish peroxidase-conjugated goat anti-rabbit or anti-167 mouse IgG (Kirkegaard and Perry Laboratories, Gaithersburg, MD) for 1 hour. Bound antibodies 168 were detected using an enhanced chemiluminescence system (ECL, GE healthcare, Piscataway, NJ). 169
170
Measurement of store-operated calcium entry (SOCE) 171
Following previously described precedures (39), cultured PASMC were seeded on coverslips, 172 underwent 24-hour quencent in smooth muscle basal medium (SMBM) containing 0.3% FBS and 173 1-hour loading with 7.5 μM fluorescent dye fura-2 AM (Molecular Probes, Eugene, OR) before 174 calcium measurement experiments. Intracellular Ca 2+ concentration was calculated by the ratio of 175 fura-2 fluorescence emitted at 510 nm after excitation at 340 nm to that after excitation at 380 nm 176 (F340/F380). The SOCE was evaluated by extracellular calcium restoration method, in which, 177 intracellular SR calcium stores within PASMC were depleted by perfusion of 10 μM cyclopiazonic 178 acid (CPA), in the presence of 1 mM EGTA and 5 μM voltage-dependent calcium channel (VDCC) 179 blocker nifedipine to exclude the influence of VDCC. By restoring extracellular calcium could we 180 measure the SOCE through store-operated calcium channel (SOCC). 181 7 182
Measurement of PASMC proliferation 183
The proliferation of PASMC was measured by the Cell Proliferation Biotrak ELISA Kit (GE 184 Healthcare) based on a BrdU incorporation assay, as previously described (41). Briefly, PASMC 185 were seeded in 96 well plates in SMBM at a density of 5×10 3 cell/well. After each different 186 treatment, the cells were then labeled with BrdU for 24-hour, fixed, blocked, antibody probed, 187 developed with TMB substrate, and stopped with sulphuric acid, following the kit instruction. The 188 optical density of wells was measured using a microplate reader (Bio-Rad) at 450 nm. 189
190
Materials and reagents 191
Unless otherwise specified, all the reagents were obtained from Sigma-Aldrich. Fura-2 AM 192 (Invitrogen) was prepared before the experiment as a 2.5 mM stock solution in 20% follistatin, gremlin1 and MGP in the lungs isolated from both normoxic and CH-exposed rats. We 211 designed specific primers for all of these members for Real-time PCR amplify (Table 1) . By using 212 real-time qPCR, we found that all of the four BMP antagonists were expressed in rat lung tissue and 213 among which, noggin was selectively down-regulated for 41.9% by hypoxic exposure (Fig. 1A) . 214
Then, by using western blotting, we found that the noggin protein level was also significantly 215 down-regulated for 45.7% (Fig. 1B-C Since previous studies strongly indicated that the excessive proliferation and migration of 221 distal PASMC act as two major events to contribute distal PA remodeling and thickening during PH 222 pathogenesis, we further explored if these antagonists express and also be regulated by hypoxia in 223 cultured PASMC. Primary cultured rat distal PASMC were serum starved and exposed to prolonged 224 hypoxia (4% O 2 ) for up to 60-hour, the period of which has been proved to induce elevation of 225 intracellular calcium concentration and cell proliferation (40). We used real-time PCR measuring 226 the mRNA transcription levels and western blotting measuring the protein levels of the four BMP 227 antagonists in PASMC upon prolonged hypoxic exposure. The RT-qPCR data showed no obvious 228 change in the mRNA levels of all these four antagonists under different time points of hypoxic 229 exposure ( Fig. 2A-D ). However, the protein level of noggin, but not the other three, was selectively 230 reduced at the 48 and 60-hour hypoxic exposure time points, accompanied with up-regulated BMP4 231 protein levels ( Fig. 2E-F) . These results indicated the possibility that the hypoxia-suppressed 232 noggin, acting in correlation with the hypoxia-induced BMP4, might account for the uncontrolled 233 proliferation and elevated intracellular calcium concentration and SOCE in PASMC. 234
235
Treatment of extrogenous recombinant noggin inhibits BMP4-induced phosphorylation of p38 236 and ERK1/2 in PASMC 237
Our previous study indicated that among the substantial cellular signaling pathways that can 238 be induced by BMP4, the p38 and ERK1/2 were considered to be essential for the induction of 239 downstream SOCE process and the expression of SOCC components TRPC1 and TRPC6 (18) . 240 Thus, we applied treatment of exogenous recombinant noggin protein and detected if noggin can 241 block BMP4-induced p38 and ERK1/2 activation. Our results showed that 200 ng/ml of noggin 242 treatment totally blocked BMP4-induced phosphorylation of p38 and ERK1/2 ( Fig. 3A-B) . 243
244
Treatment of extrogenous recombinant noggin inhibits BMP4-induced phosphorylation of 245
JAK2 and STAT3 in PASMC 246
As we know, p38 and ERK are not the only kinases to initial and mediate the cellular pro-247 proliferation subsequences. Actually, a variety of previous publications have reported that the 248 JAK2/STAT3 signaling axis can mediate smooth muscle cell proliferation upon activation from 249 upstream stimulation (1, 24, (36) (37) (38) . Therefore, we firstly found that BMP4 treatment (50 ng/ml) 250 can activate the JAK2/STAT3 signaling cascade in a time dependent manner ( Fig. 4A-B Since that at the dosage of 200 ng/ml of noggin treatment totally blocks BMP4-induced p38 257 and ERK1/2 activation, we further determined the effect of 200 ng/ml noggin on the proliferation in 258 PASMC under both normoxic and prolonged hypoxic conditions. Our results showed that firstly, 259 hypoxia markedly increased the proliferation rate for 41.6% comparing to normoxic control. Then, 260 200 ng/ml noggin significantly normalized hypoxia-elevated proliferation to basal level, without 261 altering the proliferation under normoxia (Fig. 5) . 262
263
Noggin attenuates hypoxia-elevated SOCE in PASMC 264
Furthermore, we also detected the role of noggin treatment on the SOCE and intracellular 265 calcium regulation in PASMC, since hypoxia-enhanced SOCE is considered a key regulator to 266 promote PASMC proliferation and PA remodeling (40). Our results indicated that prolonged 267 hypoxia significantly enhanced SOCE from 295.9 nM to 372.7 nM, while noggin dramatically 268 normalized hypoxia-enhanced SOCE to 275.7 nM, without markedly altering the SOCE under 269 normoxia ( Fig. 6) . 270
271
Noggin normalizes hypoxia-induced up-regulation of TRPC1 and TRPC6 in PASMC 272
Given the fact that noggin significantly normalized hypoxia-induced cell proliferation and 273 SOCE in PASMC, we therefore investigated the role of noggin on the expression of the main SOCC 274 components TRPC1 and TRPC6, which mediate SOCE. As seen in Fig Previous evidences strongly indicated the essential contribution of increased BMP4 280 expression and elevated BMP4-mediated signaling transduction in CHPH pathogenesis. In this 281 study, we investigated the expression and role of a group of four reported endogenous BMP4 282 antagonists in response to hypoxic stress in rat lung and distal PASMC. Our results indicated that 283 among these four antagonists, noggin was selectively down-regulated by hypoxic exposure in both 284 lung and PASMC, in correlation with hypoxia-elevated BMP4 expression and activity. Based on the 285 previous data, we hypothesized that hypoxia-suppressed noggin lacks the ability as an antagonist to 286 inhibit the hypoxia-evoked BMP4 activity, leading to promoted BMP4 signaling transduction, 287 which results in the transcription of numerous proliferative genes that triggers the cellular pro-288 proliferative subsequences. We further observed that extrogenous noggin treatment significantly 289 normalized hypoxia-triggered proliferation, SOCE and TRPC expression, suggesting that 290 suppressed noggin contributes to the elevated BMP4 signaling and activity under hypoxia. 291
BMPs belong to the TGF-β superfamily, which are a group of factors originally found to 292 induce ectopic bone formation when implanted subcutaneously (42). Then, considerable evidences 293 demonstrated that BMPs also act key multifunctional regulators in regulating cell proliferation, 294 differentiation, and apoptosis in different tissues (27) . BMPs exert their signals via binding with 295 type II transmembrane serine/threonine kinase receptors, thus recruit with type 1 transmembrane 296 serine/threonine kinase receptors, then activates the intracellular Smad-dependent and Smad-297 independent (e.g., ERK, JNK, and p38 MAP kinase pathways) signaling pathway in regulating 298 substantial downstream gene expression (43). Basically, three type II receptors (BMPRII, ActRIIa 299 and ActRIIb) and three type I receptors (ALK2, ALK3 and ALK6) have already been indicated to 300 be able to interfere with the BMP ligands and transduce signaling (27, 28) . Recently, a number of 301 studies suggest that the abnormal BMP signaling is participating in the disease pathogenesis of PH. 302
Many works have been done based on the finding of large chances of BMPRII mutation in the 303 idiopathic PAH (IPAH) and familial PAH (FPAH) patients (8, 17) . 304
Besides the specific BMP receptors, there are also several extracellular modulators that can 305 interfere the BMPs ligand-receptor binding to block the BMPs signaling. Noggin, MGP, gremlin1 306 and follistatin belong to such members. These soluble antagonists dampen the BMPs signaling 307 either by competitively interacting with the BMP ligands and protect them from binding with their 308 specific receptors; or by blocking the intracellular signal transduction without affecting ligand-309 receptor reaction (3, 15, 49) . Previous publications addressed the different localization of these 310 antagonists in the lung. Gremlin1 is identified in the endothelium, proximal airway epithelium and 311 alveolar epithelium (19, 29) . Follistatin is widely expressed in bronchial epithelial cells, alveolar 312 macrophages and vascular smooth muscle cells (47). MGP is excessively and broadly expressed in 313 the lung tissue (48). As it is well accepted that dysfunction of BMP4 signaling participates in and 314 contributes to the excessive proliferation of PASMC in PH, we wander the triggered BMP4 315 signaling is possibly, to some extent, due to the loss of expression and function of the antagonists. 316
Hence, we investigated the expression changes of these antagonists in response to hypoxic 317 exposure in both the lung and PASMC. Our results showed that among these four antagonists, 318 noggin was selectively down-regulated by hypoxia in both the lung and PASMC. However, by 319 applying the extrogenous noggin recombinant protein treatment, we further demonstrated that under 320 hypoxia, the restoration of noggin effectively normalized hypoxia-induced proliferation, SOCE and 321 TRPC expression. It is important to compare the blockage efficiency between noggin treatment and 322 direct BMP4 inhibition strategy (BMP4 knockdown). Actually, in one of our previous publication 323 (20), we reported that knockdown of BMP4 by using specific siRNA effectively leads to dramatic 324 decrease in the hypoxia-elevated TRPC-SOCE- [Ca 2+ ] i signaling axis. Given the fact that the 325 intracellular free calcium concentration acts a major factor to act a second messenger, enter the 326 nucleus, facilitate the transcription of a number of pro-proliferative genes and promote cell 327 proliferation (16, 30, 31), we can conclude that in PASMC, increasing direct evidences all suggest 328 BMP4 is responsible for the proliferation and intracellular calcium homeostasis, especially the 329 SOCE process. Moreover in this study, we further showed that noggin exerts similar inhibitory 330 roles, in compare with direct BMP4 knock down, on the TRPC-SOCE-proliferation signaling axis. 331 Therefore, our data suggest that a decrease in the naturally endogenous expressing BMP4 antagonist 332 noggin is potentially a main reason accounting for the elevated BMP4 signaling pathway. The 333 hypoxia-inhibited noggin accounts for, at least partly, the hypoxia-triggered BMP4 activity and 334 signaling transduction. Due to the lack of noggin's protective role, evoked BMP4 signaling leads to 335 up-regulated TRPC-SOCE axis, which eventually results in excessive PASMC proliferation in PH 336 development. While specific noggin-targeted restoration might act a potential novel strategy to 337 modulate BMP4 expression and activity, which thus mediate an attenuation of hypoxia-elevated 338 proliferation in PASMC. Moreover, we also found that beside the p38/ERK-TRPC-SOCE- [Ca 2+ ] i 339 signaling axis, BMP4 can also induce PASMC proliferation by inducing activation of JAK2/STAT3 340 signaling cascade. Our results strongly indicated that noggin can effectively attenuate BMP4-341 mediated proliferation by inhibiting both p38/ERK-TRPC-SOCE targeted calcium dependent 342 signaling axis and JAK2/STAT3 targeted calcium independent signaling axis. 343
In summary, this study presents initial evidence for the expression pattern of the four BMPs 344 antagonists in response to hypoxic stress. We observed that the hypoxia-inhibited noggin level acts 345 a key element to result in the excessive PASMC proliferation due to the uncontrolled elevated 346 BMP4 signaling, as well as the downstream triggered p38/ERK-mediated calcium dependent and 347 JAK2/STAT3-mediated calcium independent pro-proliferative signaling pathways, while strategies 348 targeting noggin restoration might be a useful way to attenuate the hypoxia-elevated proliferation of 349 PASMC. This study provides evidence of a novel potential target noggin, which can potentially 350 attenuate the hypoxia-elevated proliferation of PASMC and deserves more researches in the future 351 
